JFG
TEVA icon

Jefferies Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Jefferies Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50,500
Closed -$380K – 1988
2023
Q2 		$380K Sell
50,500
-49,500
-50% -$401K ﹤0.01% 1262
2023
Q1 		$885K Sell
100,000
-260,200
-72% -$2.57M 0.01% 938
2022
Q4 		$3.29M Buy
+360,200
New +$3.14M 0.02% 493

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Financial Group's TEVA Position: Q1 2026 in Review

Jefferies Financial Group increased its Teva Pharmaceuticals (TEVA) stake by 114% in Q1 2026, buying an estimated $540K and bringing the position to 31,564 shares worth $951K. The position accounts for 0.01% of the portfolio, ranked #946.

Jefferies Financial Group first reported a position in TEVA in Q4 2022 and has held it in 7 quarters since. The position peaked at $1.91M in Q4 2022. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Jefferies Financial Group held 31,564 shares of Teva Pharmaceuticals worth $951K as of Q1 2026.
  • Jefferies Financial Group bought 16,782 Teva Pharmaceuticals shares in Q1 2026, an estimated $540K.
  • Teva Pharmaceuticals made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #946 holding.
  • Jefferies Financial Group first reported a position in Teva Pharmaceuticals in Q4 2022 and has held it in 7 quarters since.
  • Jefferies Financial Group's Teva Pharmaceuticals position peaked at $1.91M in Q4 2022.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.